TY - JOUR
TI - Decision-making Capacity for Treatment of Psychotic Patients on Long Acting Injectable Antipsychotic Treatment
AU - Nystazaki, M.
AU - Pikouli, K.
AU - Tsapakis, E.-M.
AU - Karanikola, M.
AU - Ploumpidis, D.
AU - Alevizopoulos, G.
JO - Archives of Psychiatric Nursing
PY - 2018
VL - 32
TODO - 2
SP - 300-304
PB - W.B. Saunders
SN - 0883-9417
TODO - 10.1016/j.apnu.2017.11.019
TODO - neuroleptic agent, adult;  cross-sectional study;  decision making;  female;  Greece;  human;  informed consent;  injection;  male;  procedures;  psychology;  psychosis;  retrospective study;  schizophrenia, Adult;  Antipsychotic Agents;  Cross-Sectional Studies;  Decision Making;  Female;  Greece;  Humans;  Informed Consent;  Injections;  Male;  Psychotic Disorders;  Retrospective Studies;  Schizophrenia;  Schizophrenic Psychology
TODO - Objective: Providing informed, consent requires patients’ Decision-Making Capacity for treatment. We evaluated the Decision Making Capacity of outpatients diagnosed with schizophrenia and schizoaffective disorder on treatment with Long Acting Injectable Antipsychotic medication. Method: This is a retrospective, cross-sectional, correlational study conducted at two Depot Clinics in Athens, Greece. Participants included 65 outpatients diagnosed with schizophrenia and schizoaffective disorder on treatment with Long Acting Injectable Antipsychotics. Results: Over half of the participants showed poor understanding of the information given regarding their disease and treatment (Understanding subscale), however > 70% seemed to comprehend the relevance of this information to their medical condition (Appreciation subscale). Moreover, half of the participants reported adequate reasoning ability (Reasoning subscale), whilst patients who gained > 7% of their body weight scored statistically significantly higher in the subscales of Understanding and Appreciation. Conclusion: Our results suggest that there is a proportion of patients with significantly diminished Decision Making Capacity, hence a full assessment is recommended in order to track them down. Further research is needed to better interpret the association between antipsychotic induced weight gain and Decision Making Capacity in patients suffering from schizophrenia or schizoaffective disorder. © 2017 Elsevier Inc.
ER -